Regeneron Pharmaceuticals, Inc.

REGN · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$2,506$1,996$3,090$2,488
Short-Term Investments$5,937$5,474$5,259$6,524
Receivables$5,687$5,610$5,561$6,212
Inventory$3,254$3,206$3,192$3,087
Other Curr. Assets$596$574$469$349
Total Curr. Assets$17,981$16,860$17,572$18,661
Property Plant & Equip (Net)$5,002$4,841$4,694$4,600
Goodwill$0$0$0$0
Intangibles$1,381$1,352$1,167$1,149
Long-Term Investments$10,286$10,058$9,276$8,900
Tax Assets$3,847$3,572$3,443$3,314
Other NC Assets$1,673$1,537$1,393$1,136
Total NC Assets$22,189$21,360$19,974$19,099
Other Assets$0$0$0$0
Total Assets$40,169$38,219$37,545$37,759
Liabilities
Payables$904$724$706$790
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$213
Deferred Revenue$546$482$619$628
Other Curr. Liab.$2,976$2,461$2,242$2,314
Total Curr. Liab.$4,425$3,667$3,567$3,944
LT Debt$2,706$2,705$2,705$2,704
Deferred Rev, NC$219$206$212$186
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,862$1,702$1,674$1,571
Total NC Liab.$4,787$4,613$4,591$4,462
Other Liabilities$0$0$0$0
Cap. Leases$720$720$720$720
Total Liabilities$9,212$8,280$8,158$8,406
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings$35,046$33,680$32,384$31,673
AOCI$69$53$29-$8
Other Equity-$4,157-$3,794-$3,026-$2,312
Total Equity$30,958$29,939$29,388$29,354
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$40,169$38,219$37,545$37,759
Net Debt$199$709-$385$216
Regeneron Pharmaceuticals, Inc. (REGN) Financial Statements & Key Stats | AlphaPilot